Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?
Woelber L, Bommert M, Prieske K, Fischer I, Zu Eulenburg C, Vettorazzi E, Harter P, Jueckstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Beckmann M, Mustea A, Meier W, Wimberger P, Hanker L, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Mahner S, Schmalfeldt B, Jaeger A. Woelber L, et al. Among authors: hilpert f. Geburtshilfe Frauenheilkd. 2020 Dec;80(12):1221-1228. doi: 10.1055/a-1120-0138. Epub 2020 Dec 3. Geburtshilfe Frauenheilkd. 2020. PMID: 33293730 Free PMC article.
Clinical picture: nail changes secondary to docetaxel.
Wasner G, Hilpert F, Baron R, Pfisterer J. Wasner G, et al. Among authors: hilpert f. Lancet. 2001 Mar 24;357(9260):910. doi: 10.1016/s0140-6736(00)04210-0. Lancet. 2001. PMID: 11289346 No abstract available.
State-of-the-art first-line treatment of ovarian cancer.
Pfisterer J, Hilpert F, Du Bois A, Meier W, Wagner U. Pfisterer J, et al. Among authors: hilpert f. Onkologie. 2003 Oct;26(5):446-50. doi: 10.1159/000072977. Onkologie. 2003. PMID: 14605460 Review.
[Advances in the treatment of ovarian carcinoma].
Pfisterer J, du Bois A, Hilpert F, Wagner U, Meier W. Pfisterer J, et al. Among authors: hilpert f. Dtsch Med Wochenschr. 2004 Feb 20;129(8):379-84. doi: 10.1055/s-2004-819897. Dtsch Med Wochenschr. 2004. PMID: 14961446 Review. German. No abstract available.
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany.
Pfisterer J, Du Bois A, Bentz EK, Kommoss F, Harter P, Huober J, Schmalfeldt B, Burchardi N, Arnold N, Hilpert F. Pfisterer J, et al. Among authors: hilpert f. Int J Gynecol Cancer. 2009 Jan;19(1):109-15. doi: 10.1111/IGC.0b013e3181991a7c. Int J Gynecol Cancer. 2009. PMID: 19258951 Clinical Trial.
Role of cytoreductive surgery in recurrent ovarian cancer.
Harter P, Hilpert F, Mahner S, Kommoss S, Heitz F, du Bois A. Harter P, et al. Among authors: hilpert f. Expert Rev Anticancer Ther. 2009 Jul;9(7):917-22. doi: 10.1586/era.09.49. Expert Rev Anticancer Ther. 2009. PMID: 19589031 Review.
Surgery for recurrent ovarian cancer.
Heitz F, du Bois A, Kurzeder C, Pfisterer J, Barinoff J, Grabowski J, Hilpert F, Mahner S, Harter P. Heitz F, et al. Among authors: hilpert f. Womens Health (Lond). 2011 Sep;7(5):529-35. doi: 10.2217/whe.11.52. Womens Health (Lond). 2011. PMID: 21879821 Free article. Review.
160 results